Inventor · San Diego, CA, US

Christopher Larson

22Patents
5h-index
34Co-inventors
69Inventor score

Filing activity: Apr 24, 2001 → Apr 29, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US7863012B2 Analysis of circulating tumor cells, fragments, and debris Emerging Cross-Sectional Technologies 124 Expired
US8329422B2 Analysis of circulating tumor cells, fragments, and debris Emerging Cross-Sectional Technologies 77 Active
US6617136B2 Biological sample processing methods and compositions that include surfactants Chemistry; Metallurgy 46 Expired
US9546560B2 Compact double grounded mechanical carbon seal Emerging Cross-Sectional Technologies 9 Active
US8919134B2 Intershaft seal with support linkage Mechanical Engineering; Lighting; Heating 6 Active
US7749999B2 Alpha-ketoamides and derivatives thereof Emerging Cross-Sectional Technologies 4 Expired
US7919617B2 Cytokine inhibitors Emerging Cross-Sectional Technologies 4 Active
US7897599B2 Cytokine inhibitors Emerging Cross-Sectional Technologies 4 Active
US10167734B2 Buffer airflow to bearing compartment Emerging Cross-Sectional Technologies 3 Active
US10906957B2 Immunomodulatory fusion proteins Chemistry; Metallurgy 2 Active
US11253608B2 Recombinant adenoviruses carrying transgenes Chemistry; Metallurgy 1 Active
US10557774B2 Mattress firmness testing process and system Performing Operations; Transporting 1 Active
US11834492B2 Human IL-10 receptor alpha fusion proteins Chemistry; Metallurgy 1 Active
US12280123B2 Recombinant adenoviruses carrying transgenes Chemistry; Metallurgy 0 Active
US12054530B2 Immunomodulatory fusion proteins Chemistry; Metallurgy 0 Active
US9765692B2 Systems and methods for load diversion around load sensitive parts Mechanical Engineering; Lighting; Heating 0 Active
US12295976B2 Personalized cancer vaccines Emerging Cross-Sectional Technologies 0 Active
USD995157S1 Mattress support gel General 0 Active
US12291726B2 A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter Chemistry; Metallurgy 0 Active
US11999973B2 Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter Chemistry; Metallurgy 0 Active
US11459956B2 Face seal arrangement with reduced balance ratio Mechanical Engineering; Lighting; Heating 0 Active
US12036247B2 Multiple transgene recombinant adenovirus Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.